CD4 and neoplasm: Although effective immunotherapy promotes the killing of cancer cells by cytotoxic T cells [10], CD4+ helper T cells, regulatory T cells (Tregs), effector T-cells, macrophages, and neutrophils are also important immune factors that can either promote or block tumor development [29].